MK-0633

MK-0633 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0633, covering 2016-01-22 to 2016-01-22. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED) [Phase 2]